Indiana

  Drug Litigation.
HOME ABOUT US FAQ'S RESOURCES CONTACT US FREE CASE REVIEW
February 06, 2012
Drug-Litigation
             
 
Selecting an attorney for legal cases is a very important decision. Please enter your information below to receive a Free Consultation from an attorney in your area:
 
Zip Code:   
 

Drug Litigation News

 

Office of Safe and Drug-Free Schools Convenes First Advisory Committee Meeting

Mental health and wellness experts, education leaders, law and drug-enforcement officials, a criminal judge and juvenile justice advocates from around the country came together Monday and Tuesday, June 12-13, in Washington, D.C., for their first meeting as members of the newly formed Safe and Drug-Free Schools and Communities Advisory Committee. The committee, appointed by U.S. Secretary of Education Margaret Spellings, is charged with evaluating three areas: the Office of Safe and Drug-Free Schools and Communities: State Grants program, Persistently Dangerous Schools and the Unsafe School Choice Option, and requirements for data under No Child Left Behind. "Students need a safe place to learn, and the Safe and Drug-Free Schools and Communities Advisory Committee will play a vital role as we move forward in ensuring that our students have safe and drug-free schools," Secretary Spellings said.

The committee, chaired by David Long, superintendent of Riverside County Public Schools in Riverside, Calif., consists of 11 expert panelists from across the country and eight ex-officio members. Members serve staggered terms, ranging from one to three years, in order to retain an experienced core of members. Approximately 12 additional meetings will take place between now and June 30, 2007, when the committee is to submit a written report of its findings to the Secretary. Once the report is completed, members will continue to meet to discuss issues relating to safe and drug-free schools. "This committee, which is made up of passionate citizens from across the country who have high levels of expertise and years of experience in safe schools and crisis planning and mental health research, will address questions, have lively discussions and ultimately submit a report to the Secretary with our findings," Chairman Long said. "And we are excited about the process."

While Monday's meeting included an overview of the various programs within the Office of Safe and Drug-Free Schools, on Tuesday, the committee also voted on the dates for its next two meetings and discussed prioritizing and streamlining issues within the three major categories on which they are to report to the Secretary. Members also decided to solicit the help of focus groups, which would consist of experts in the field, to assist with recommendations to the Secretary. No Child Left Behind authorizes the committee and the Federal Advisory Committee Act governs it. As mandated by its charter, the Safe and Drug-Free Schools and Communities Advisory Committee will announce all of its meetings, which are open to the public, in the Federal Register.

Contact our Indiana Drug Litigation Lawyer Now!

 

 
Did You Know?    
 
 
Many over the counter drugs were once prescription drugs
Americans buy about 5 billion over-the-counter drugs each year, according to government estimates, to treat their headaches, heartburn, coughs and colds, and other routine health problems. According to the Consumer Healthcare Products Association, a trade

 


  Newsroom  
 


News about Drug Litigation cases in Indiana and nationwide:

Experts Fault New FDA Drug Label Changes
WEDNESDAY, June 7 (HealthDay News) -- Experts say the new labeling system for prescription drugs about to launch in the United States will not radi...
Read more >


Study Shows Lag Time
Study Shows Lag Time in Reporting Drug Withdrawal Decisions to Healthcare Professionals

Charlottesville, Va., May 23, 2006...

Read more >


Drugs Into The U.S. Marketplace
It will focus in particular on whether certain "later-listed" patents or inappropriate patent submissions by the sponsors of innovator drug product...
Read more >


More Drug Litigation News >

 
 

Drug Litigation Terms

 


Today's Terms

Therapeutic Equivalence (TE)

Definition:
Drug products classified as therapeutically equivalent can be substituted with the full expectation that the substituted product will produce the same clinical effect and safety profile as the prescribed product.

Patient Package Insert (PPI)

Definition:
A patient package insert contains information for patients' understanding of how to safely use a drug product.

Generic Drug

Definition:
A generic drug is the same as a brand name drug in dosage, safety, strength, how it is taken, quality, performance, and intended use.

More Drug Litigation Terms >

 

Drug Litigation Resources

 


Search Drug Litigation resources in our resource center:

More Resources >

 

Drug Litigation Hot Topics

 


Topics Related to Drug Litigation:

  • Adverse Effects
  • Prescription Drugs
  • Over the Counter Drugs
  • Drug Recalls
  • Dosage Errors
  • Drug Company Liability
  • Drug Company Negligence
  • More Drug Litigation Topics >

    Indiana Drug Litigation Attorney

     
    If you live in the following cities and need an Drug Litigation attorney you should contact our Drug Litigation Attorney as soon as possible:

    • Bloomington
    • Brownsburg
    • Carmel
    • Columbus
    • Connersville
    • Crawfordsville
    • Crown Point
    • East Chicago
    • Elkhart
    • Evansville
    • Fishers
    • Fort Wayne
    • Franklin
    • Goshen
    • Granger
    • Greenfield
    • Greenwood
    • Hobart
    • Huntington
    • Indianapolis
    • Jeffersonville
    • Kokomo
    • La Porte
    • Lafayette
    • Logansport
    • Marion
    • Martinsville
    • Merrillville
    • Michigan City
    • Mishawaka
    • Muncie
    • New Albany
    • New Castle
    • Newburgh
    • Noblesville
    • Peru
    • Plainfield
    • Portage
    • Richmond
    • Seymour
    • Shelbyville
    • South Bend
    • Terre Haute
    • Valparaiso
    • Vincennes
    • West Lafayette
     


    Legal Disclaimers
    All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on Indiana Drug Litigation.com is not intended to be legal advice, but merely conveys general information related to legal issues commonly encountered. Your access to and use of this website is subject to additional Terms and Conditions.

    Local Professional? Generate new business today
    Call 866-227-9356 or contact a sales rep


    This site is part of the LawFirms.com Network
    ©2012 ExpertHub, wholly owned subsidiary of MoxyMedia, Inc.